Abstract:Background Many patients with obstructive sleep apnea syndrome (OSAS) have complicated with hypertension and may be prescribed with antihypertension medications to control their blood pressure. But whether antihypertension medications can also decrease arterial stiffness or control the blood pressure increasing following obstructive events is not well described. This study aimed to investigate whether antihypertensive medications can ameliorate the changes in arterial stiffness and blood pressure associated with OSA.Methods Sixty-one OSAS patients [13 women, 48 men, mean age (53. 4 +/- 12. 3) years], 26 normotensive patients (N), 7 hypertensive patients on no antihypertension medications (H), and 28 hypertensive patients on various combination antihypertension therapy (HM), were prospectively diagnosed with standard nocturnal polysomnography. Beat-to-beat blood pressure was continuously recorded from the radial artery by applanation tonometry during baseline sleep. As a measure of arterial stiffness, arterial augmentation index (AAI) was calculated as the ratio of augmented systolic blood pressure (SBP) to pulse pressure and expressed as a percentage for the following conditions: awakening, the first 10 ( "early apnea") and last 10 ( "late apnea") cardiac cycles of obstructive events (apnea orhypopnea), and the first 15 cardiac cycles following event termination ("post apnea") for all events with nadir O-2 saturation less than or equal to89%.Results Systolic blood pressure (SBP) post-apnea [(142.74 +/- 13.06) mmHg (N), (137.06 +/- 26.56) mmHg (H), ( 136.94 +/- 14.1) mmHg (HM)] was significantly increased from awakening 135.76 +/- 14.76) mmHg (N), (135.58 +/- 23.17) mmHg (H), (129.77 +/- 14.00) mmHg (HM)], early apnea [(130.53 +/- 12.65) mmHg (N), ( 124.47 +/- 24.97) mmHg (H), 126.04 +/-13.12) mmHg (HM)], and late apnea [(129.8 +/- 12.68) mmHg(N), (124.78 +/- 25.15) mmHg (H), ( 124.48 +/- 13.82) mmHg (HM)] respectively ( P < 0.001, repeated measures ANOVA). AAI was significantly increased for the N group ( P < 0.001) from awakening to late apnea [(10.45 +/- 2.62)% vs (14.43 +/- 3.21)%] and from early apnea to late apnea [(10.61 +/- 2.34)% vs 14.43 +/- 3.21%] and also for H group ( P < 0.05) from awakening to late apnea [(11.23 +/- 3.87)% vs 16.2 +/- 8.02]% and from early apnea to late apnea [(11.75 +/- 3.79)% vs (16.32 +/- 8.02)%]. Meanwhile, no significant differences in AAI among awakening, early apnea, late apnea, and post-apnea conditions were found in HM group.Conclusions The current data demonstrate that systemic blood pressure increases significantly during the postapneic phase of OSAS, compared with that during awakening and intra-apnea phases even with the use of combined antihypertensive therapy which couldnormalize BP during awakening in the hypertensive patients. However, increases in arterial stiffness during obstructive events could be ameliorated by combined. antihypertension medications.

Effects of short-term continuous positive airway pressure treatment on arterial stiffness in patients with obstructive sleep apnea hypopnea syndrome]

Effects of continuous positive airway pressure treatment and withdrawal in patients with obstructive sleep apnea on arterial stiffness and central BP.

Effect of Acute Hypoxia and Hypercapnia on Arterial Stiffness and Blood Pressure in Patients with Obstructive Sleep Apnea Hypopnea Syndrome

Effects Of Anti Hypertensives On Arterial Responses Associated With Obstructive Sleep Apneas

Influence of Continuous Positive Airway Pressure Treatment on Cardiovascular Risk Factors in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

Beneficial Response of Blood Pressure to Short-Term Continuous Positive Airway Pressure in Chinese Patients with Obstructive Sleep Apnea-Hypopnea Syndrome.

Effect of continuous positive airway pressure therapy on blood pressure variability of obstructive sleep apnea hypopnea syndrome

Arterial Stiffness Changes and Plasma Renin-Angiotensin-Aldosterone in Patients with Hypertention and Obstructive Sleep Apnea-Hypopnea Syndrome

Effects of Continuous Positive Airway Pressure Treatment on Vascular Function in a Real-Life Cohort of Elderly Patients with Obstructive Sleep Apnoea Syndrome

[Impact of Long-Term Continuous Positive Airway Pressure Treatment for Patients with Obstructive Sleep Apnea Syndrome].

A randomized controlled trial on ambulatory blood pressure lowering effect of CPAP in patients with obstructive sleep apnea and nocturnal hypertension

The changes of AHI after long-term CPAP in patients with comorbid OSA and cardiovascular disease

Continuous positive airway pressure for treating high blood pressure of patients with obstructive sleep apnea-hypopnea syndrome：a meta-analysis

Impact of CPAP Therapy on the Autonomic Nervous System

Continuous Positive Airway Pressure Effectively Ameliorates Arrhythmias in Patients with Obstructive Sleep Apnea-Hypopnea Via Counteracting the Inflammation

Effects of Continuous Positive Airway Pressure on C-reactive Protein and Interleukin-6 in Obstructive Sleep Apnea-hypopnea Syndrome with Hypertension

Effects of Continuous Positive Airway Pressure on Serum Inflammatory Factors in Coronary Heart Disease Patients Complicated with Obstructive Sleep Apnea-Hypopnea Syndrome

Continuous positive airway pressure adherence and blood pressure lowering in patients with obstructive sleep apnoea syndrome and nocturnal hypertension

[Effects of Oral Appliance Treatment Upon Blood Pressure in Mild to Moderate Obstructive Sleep Apnea-Hypopnea Syndrome].

[Effects of Continuous Positive Airway Pressure on Daytime Sleepiness in Patients with Severe Obstructive Sleep Apnea Syndrome].

Effects of short-term continuous positive airway pressure ventilation on chronic kidney disease in patients with obstructive sleep apnea/hypopnea syndrome